NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zota Health Care LImited (NSE: ZOTA)

 
ZOTA Technical Analysis
3
As on 24th Apr 2024 ZOTA SHARE Price closed @ 492.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 432.18 & Buy for SHORT-TERM with Stoploss of 492.50 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ZOTASHARE Price

Open 488.70 Change Price %
High 495.35 1 Day 6.95 1.43
Low 487.55 1 Week 0.90 0.18
Close 492.50 1 Month 14.25 2.98
Volume 10611 1 Year 218.35 79.65
52 Week High 481.95 | 52 Week Low 234.55
 
NSE INDIA Most Active Stocks
IDEA 13.10 -9.03%
SAIL 164.65 8.14%
YESBANK 25.45 -0.78%
TATASTEEL 165.55 2.73%
IRFC 149.00 0.85%
SOUTHBANK 29.10 1.04%
MRPL 248.70 10.75%
SUZLON 41.80 -0.12%
BEL 236.50 0.92%
RAMASTEEL 14.00 2.56%
 
NSE INDIA Top Gainers Stocks
ROML 63.05 19.98%
COMPUSOFT 35.20 19.93%
SHRADHA 78.55 19.83%
STEELCITY 102.95 19.78%
WEIZMANIND 142.25 19.59%
TEMBO 240.90 18.61%
CHENNPETRO 1075.00 15.82%
YUKEN 1180.65 13.81%
ORIENTCEM 230.50 12.85%
AEGISCHEM 604.50 12.41%
 
NSE INDIA Top Losers Stocks
BBL 3320.90 -51.12%
BBL 3320.90 -51.12%
BBL 3320.90 -51.12%
BBL 3320.90 -51.12%
IDEA 13.10 -9.03%
IDEA 13.10 -9.03%
IDEA 13.10 -9.03%
HUHTAMAKI 318.00 -8.19%
SHK 206.60 -7.64%
SHK 206.60 -7.64%
 
 
ZOTA
Daily Charts
ZOTA
Intraday Charts
Whats New @
Bazaartrend
ZOTA
Free Analysis
 
ZOTA Important Levels Intraday
RESISTANCE507.53
RESISTANCE502.71
RESISTANCE499.73
RESISTANCE496.75
SUPPORT488.25
SUPPORT485.27
SUPPORT482.29
SUPPORT477.47
 
ZOTA Target April 2024
4th UP Target693.83
3rd UP Target638.24
2nd UP Target603.88
1st UP Target569.52
1st DOWN Target471.48
2nd DOWN Target437.12
3rd DOWN Target402.76
4th DOWN Target347.17
 
ZOTA Weekly Target
4th UP Target571.59
3rd UP Target542.70
2nd UP Target524.84
1st UP Target506.98
1st DOWN Target456.02
2nd DOWN Target438.16
3rd DOWN Target420.30
4th DOWN Target391.41
 
ZOTA Target2024
4th UP Target1015.67
3rd UP Target841.46
2nd UP Target733.77
1st UP Target626.09
1st DOWN Target318.81
2nd DOWN Target211.13
3rd DOWN Target103.44
4th DOWN Target-70.77
 
 
ZOTA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is -74.95 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 160.12
10 Day Avg Volume Traded 2.00 % More then 10 Day Average Volume
 
ZOTA Other Details
Segment EQ
Market Capital 9035734016.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ZOTA Address
ZOTA
 
ZOTA Latest News
 
Your Comments and Response on Zota Health Care LImited
 
ZOTA Business Profile
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India. Address: Zota House, Surat, India, 395002
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service